How to buy ensidipine generic drugs

Ensidipine is a targeted therapy for acute myeloid leukemia (AML), specifically for those patients who carry IDH2 gene mutations. As an inhibitor of isocitrate dehydrogenase-2 (IDH2), it reduces the levels of the abnormal metabolite 2-hydroxyglutarate (2-HG) by precisely inhibiting the activity of mutated IDH2 enzyme. This method helps restore the normal metabolism and differentiation of leukemia cells, thereby achieving the purpose of treating AML.

In clinical trials, ensidipine has shown positive effects on AML patients with IDH2 mutations, and can effectively extend the patient's survival and improve their quality of life. The recommended starting dose is 100 mg per day, which needs to be taken orally as a whole tablet and can be taken with food, making it easy to use.

Generic drugs of ensidipine are also currently available on the market. These generic drugs contain the same active ingredients as the original drugs and therefore have similar therapeutic effects. For patients who require long-term medication, generic drugs are usually more affordable and can reduce the financial burden. However, when choosing a generic drug, you also need to ensure that it comes from a reliable source to ensure the quality and safety of the drug.

Encidipine is currently not available on the market in China, so there is no way to include it in domestic medical insurance reimbursement items. If patients need this drug, they can only purchase it from overseas or contact a regular overseas medical consulting company for information. It is understood that encidipine has related generic drugs on the market abroad. There are two generic versions of ensidipine available overseas, produced by Ziska Pharmaceuticals of Bangladesh and Lucius Pharmaceuticals of Laos. The price of 30 tablets is about more than 2,000 yuan. If the patient has more questions about ensidipine, please consult a regular overseas medical consulting company.

In general, whether it is an original drug or a generic drug, ensidipine isAML patients with IDH2 gene mutations provide new treatment options and bring more hope for survival. However, you should follow your doctor's advice when using it, pay attention to possible side effects, and conduct regular examinations to ensure the effectiveness and safety of the treatment.